Product containing methenamine and monobasic sodium phosphate (medicinal product)
RxNorm 819833
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 819833 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Product containing methenamine and monobasic sodium phosphate (medicinal product).
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
MIN
Multiple Ingredients (MIN):
Methenamine / sodium phosphate
(Atom ID: 12353783)
PT
Designated preferred name (PT):
Methenamine- and monobasic sodium phosphate-containing product
(Atom ID: 10806954)
FN
Full form of descriptor (FN):
Product containing methenamine and monobasic sodium phosphate (medicinal product)
(Atom ID: 10307861)
Patient Education
Methenamine
Methenamine, an antibiotic, eliminates bacteria that cause urinary tract infections. It usually is used on a long-term basis to treat chronic infections and to prevent recurrence of infections. Antibiotics will not work for colds, flu, or other viral infections. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
[Learn More]
Sodium Phosphate
Sodium phosphate is used in adults 18 years of age or older to empty the colon (large intestine, bowel) before a colonoscopy (examination of the inside of the colon to check for colon cancer and other abnormalities) so that the doctor will have a clear view of the walls of the colon. Sodium phosphate is in a class of medications called saline laxatives. It works by causing diarrhea so that the stool can be emptied from the colon.
[Learn More]
* Please review the disclaimer below.